APA (7th ed.) Citation

DA, E., MK, S., MA, A., ES, T., AF, E., WS, S., . . . B, F. (2025). Antiplatelet therapy through inhibition of P2Y12 and phosphodiesterase receptors by novel synthesis 1,3-dicyclohexylpyrimidine-2,4(1H,3H)-dione derivatives with computational evaluation. Bioorganic chemistry, 165, 109009. https://doi.org/10.1016/j.bioorg.2025.109009

Chicago Style (17th ed.) Citation

DA, Elsayed, Soltan MK, Abd-El-Maksoud MA, Tantawy ES, El-Sayed AF, Shehab WS, Saeed A, and Farag B. "Antiplatelet Therapy Through Inhibition of P2Y12 and Phosphodiesterase Receptors by Novel Synthesis 1,3-dicyclohexylpyrimidine-2,4(1H,3H)-dione Derivatives with Computational Evaluation." Bioorganic Chemistry 165 (2025): 109009. https://doi.org/10.1016/j.bioorg.2025.109009.

MLA (9th ed.) Citation

DA, Elsayed, et al. "Antiplatelet Therapy Through Inhibition of P2Y12 and Phosphodiesterase Receptors by Novel Synthesis 1,3-dicyclohexylpyrimidine-2,4(1H,3H)-dione Derivatives with Computational Evaluation." Bioorganic Chemistry, vol. 165, 2025, p. 109009, https://doi.org/10.1016/j.bioorg.2025.109009.